Have a personal or library account? Click to login
Haemophilia A management with emicizumab: A survey of haematologists in the United States Cover

Haemophilia A management with emicizumab: A survey of haematologists in the United States

The Journal of Haemophilia Practice
Volume 8 (2021): Issue 1 (January 2021)
By: Anisha M. Patel,  Wendy E. Owens,  Kathleen Poulos,  Karina Raimundo,  Gabriel Wong,  Janet Bernard,  Janet Powers and  Richard H. Ko  
Open Access
|Mar 2022

Authors

Anisha M. Patel

patel.anisha@gene.com

Genentech, Inc., South San Francisco, USA

Wendy E. Owens

Genentech, Inc., South San Francisco, USA

Kathleen Poulos

Ferrum Health, Inc., Waltham

Karina Raimundo

Genentech, Inc., South San Francisco, USA

Gabriel Wong

Genentech, Inc., Seagen Inc., South San Francisco

Janet Bernard

JANET BERNARD MedPanel, Waltham, USA

Janet Powers

Waltham, USA

Richard H. Ko

Genentech, Inc., South San Francisco, USA
DOI: https://doi.org/10.2478/jhp-2021-0017 | Journal eISSN: 2055-3390
Journal RSS Feed
Language: English
Page range: 155 - 182
Published on: Mar 2, 2022
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
emicizumab,
haemophilia A,
physicians,
surveys and questionnaires
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other,
Pharmacy,
Pharmacology

© 2022 Anisha M. Patel, Wendy E. Owens, Kathleen Poulos, Karina Raimundo, Gabriel Wong, Janet Bernard, Janet Powers, Richard H. Ko, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 8 (2021): Issue 1 (January 2021)Next article